Fosigotifator clinical trials

Single Patient Investigational Treatment for Cree Leukoencephalopathy

This study is for a very rare, severe brain condition called Cree Leukoencephalopathy (CLE). There's no current cure. It tests a new drug called fosigotifator to see if it can slow down or stop the brain damage and improve a patient's health.